69°

Topics

Pharmaceutical Industry
Pershing Square names those it wants on Allergan's board
Pershing Square names those it wants on Allergan's board

Investment firm Pershing Square Capital Management on Monday named the six people it will nominate for spots on the board of Allergan Inc. of Irvine as it tries to buy the Botox maker. Pershing Square's Bill Ackman and Valeant Pharmaceuticals International Inc. want to buy Allergan and have offered about $53 billion in cash and stock for the company. Allergan has rejected several offers and adopted a "poison pill" measure to block a takeover. Pershing Square's nominees are Betsy Atkins, Cathleen Black, Fredric Eshelman, Steven Shulman, David Wilson and John Zillmer. There are nine directors on Allergan's board, and if all six nominees were elected, Pershing Square would have majority...

Loading